IP Library › Granted Patent US 12,383,610
Granted Patent B2
US 12,383,610 · App. 17/909,917 · Granted Aug 12, 2025

Vaccine for protection against

Inventor: Antonius Arnoldus Christiaan Jacobs (Kessel, NL)
Assignee: Intervet Inc.
A61K39/092A61P31/04A61P37/04A61K2039/552A61K2039/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,383,610
App. No.
17/909,917
Granted
Aug 12, 2025
Kind
B2
Abstract

The present invention pertains to a vaccine comprising in combination an IgM protease antigen of Streptococcus suis and a Streptococcus suis bacterin of serotype (9), sequence type (16), for use in a method for protecting pigs against a pathogenic infection with Streptococcus suis serotype (9), sequence type (16).

Claims (14)

1. A method for protecting pigs against a pathogenic infection with Streptococcus suis serotype 9, sequence type 16 comprising administering to a pig a combination of an IgM protease antigen of Streptococcus suis and a Streptococcus suis bacterin serotype 9, sequence type 16.

2. The method of claim 1 , wherein the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin are comprised in a single composition for administration to the pigs.

3. The method of claim 1 , wherein the IgM protease antigen of Streptococcus suis is an IgM protease of Streptococcus suis serotype 2.

4. The method of claim 1 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin to the pigs at an age of at most 35 days.

5. The method of claim 1 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin before an age at which the pigs are weaned.

6. The method of claim 2 , wherein the IgM protease antigen of Streptococcus suis is an IgM protease of Streptococcus suis serotype 2.

7. The method of claim 6 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin to the pigs at an age of at most 35 days.

8. The method of claim 3 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin to the pigs at an age of at most 35 days.

9. The method of claim 8 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin before an age at which the pigs are weaned.

10. The method of claim 7 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin before an age at which the pigs are weaned.

11. The method of claim 6 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin before an age at which the pigs are weaned.

12. The method of claim 4 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin before an age at which the pigs are weaned.

13. The method of claim 3 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin before an age at which the pigs are weaned.

14. The method of claim 2 , wherein the method comprises administering the IgM protease antigen of Streptococcus suis and the Streptococcus suis bacterin before an age at which the pigs are weaned.

Assignments (3)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2022
From: JACOBS, ANTONIUS ARNOLDUS CHRISTIAAN
To: INTERVET INTERNATIONAL B.V.
Reel/Frame 061016/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2022
From: INTERVET INTERNATIONAL B.V.
To: INTERVET INC.
Reel/Frame 061017/0364 →
Priority Claims (1)
EP 20163206 · Mar 14, 2020 · regional
Continuity (1)
Related Publication 20240197851A1 · Jun 20, 2024
References Cited (14)
WO 2015181356A1 · 2015 [cited by applicant]
WO 2019115741A1 · 2019 [cited by applicant]
WO 2019115743A1 · 2019 [cited by applicant]
WO 2020094762A1 · 2020 [cited by applicant]
Buttner, Nadine et al., [cited by applicant]
Haesebrouck, Freddy et al., Efficacy of vaccines against bacterial diseases in swine: What can we expect?, Veterinary Microbiology, 2004, 255-268, 100(3-4). [cited by applicant]
Hsueh, Kai-Jan et al., Immunization with Streptococcus suis bacterin plus recombinant Sao protein in sows conveys passive immunity to their piglets, BMC Veterinary Research, 2016, 1-9, 13. [cited by applicant]
King, Samantha J et al, Development of a Multilocus Sequence Typing Scheme for the Pig Pathogen [cited by applicant]
Reickmann et al, Vaccination with the immunoglobulin M-degrading enzyme of [cited by applicant]
Seele, J et al, The immunoglobulin M-degrading enzyme of [cited by applicant]
Segura, M., [cited by applicant]
Harkevich D.A., Pharmacology: Textbook, Ways of Drug Administration. Suction, M.: GEOTAR-Media, 10th Edition, 908, 42, 2010. [cited by applicant]
Kharkevich, D.A., Pharmacology, Moscow: GEOTAR-Media, Textbook for HS, 10th Ed., 73-74, 2010. [cited by applicant]
Svistunov, A.A., et al., Pharmacology: Textbook, M.: Laboratory of Knowledge, N/A, 55-56, 2017. [cited by applicant]